More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$14.17B
EPS
1.84
P/E ratio
38.6
Price to sales
0.88
Dividend yield
--
Beta
1.776728
Previous close
$71.45
Today's open
$71.21
Day's range
$68.52 - $71.41
52 week range
$30.64 - $73.75
show more
CEO
Jon Rousseau
Employees
23500
Headquarters
Louisville, KY
Exchange
Nasdaq Global Select
Shares outstanding
198984612
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
BrightSpring Health Services, Inc. (BTSG) Presents at 2026 UBS Global Healthcare Conference Transcript
BrightSpring Health Services, Inc. (BTSG) Presents at 2026 UBS Global Healthcare Conference Transcript
Seeking Alpha • Nov 10, 2026

Buy 5 Growth Stocks to Enhance Your Portfolio Returns in November
PWR, BTSG, PSX, VLO and DINO are five growth stocks poised to strengthen portfolio returns in the remaining days of 2026.
Zacks Investment Research • Nov 10, 2026

Why Fast-paced Mover BrightSpring Health Services, Inc. (BTSG) Is a Great Choice for Value Investors
BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Nov 9, 2026

BTSG vs. CAI: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Caris Life Sciences,?Inc. (CAI). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 9, 2026

IPO Stock Of The Week: Health Firm BrightSpring Poised To Hit Buy Point Despite Volatile Market
IPO Stock Of The Week BrightSpring stock is approaching a fresh buy point despite heavy stock market losses this past week.
Investors Business Daily • Nov 6, 2026

BTSG Jumps 11.3% in One Week as Strong Growth Tests Its Valuation
BrightSpring surged 11.3% in a week as strong pharmacy growth, rising profits and higher 2026 guidance fueled gains, but its premium valuation raises concerns.
Zacks Investment Research • Nov 5, 2026

Here's Why You Should Retain BTSG Stock in Your Portfolio for Now
BrightSpring's specialty pharmacy growth, Provider Services expansion and operational gains fuel optimism, but IRA pressures and integration risks remain.
Zacks Investment Research • Nov 4, 2026

Why BrightSpring Health Services, Inc. (BTSG) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 3, 2026

BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
BrightSpring raises 2026 guidance after a Q3 earnings beat, as specialty drug launches and home health gains support its outlook for organic growth in 2027.
Zacks Investment Research • Nov 2, 2026

BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BTSG's Q3 2026 earnings surge 80% as strong pharmacy and home health growth fuel a revenue beat, margin expansion and higher full-year guidance.
Zacks Investment Research • Nov 2, 2026

¹ Disclosures

Open an M1 investment account to buy and sell BrightSpring Health Services Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.